🇺🇸 Coenzyme Q 10 in United States

326 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 41 reports (12.58%)
  2. Diarrhoea — 38 reports (11.66%)
  3. Nausea — 36 reports (11.04%)
  4. Headache — 35 reports (10.74%)
  5. Asthenia — 33 reports (10.12%)
  6. Dizziness — 31 reports (9.51%)
  7. Eye Pain — 30 reports (9.2%)
  8. Dyspnoea — 28 reports (8.59%)
  9. Urinary Tract Infection — 28 reports (8.59%)
  10. Product Dose Omission Issue — 26 reports (7.98%)

Source database →

Coenzyme Q 10 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Coenzyme Q 10 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Coenzyme Q 10 in United States?

Universitas Diponegoro is the originator. The local marketing authorisation holder may differ — check the official source linked above.